13.54
13.54 (0%)
As of Feb 14, 2025
Takeda Pharmaceutical Co Ltd [TAK]
Source:
Company Overview
Takeda Pharmaceutical Co Ltd is a patient-focused, values-based, R&D-driven global biopharmaceutical company with a diverse portfolio, engaged primarily in the research, development, production and global commercialization of biopharmaceutical products.
| Country | United States |
| Headquarters | tokyo |
| Phone Number | 81 3 3278-2306 |
| Industry | manufacturing |
| CEO | Takeda Pharmaceutical Co Ltd |
| Website | www.takeda.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $4,263,762 |
| Operating Profit | $214,075 |
| Net Income | $144,197 |
| Net Cash | $-101,934 |
Profit Ratios
| Gross Margin | $5,690,440 |
| Operating Margin | 5 |
| Profit as % of Revenues | 3,946.3% |
| Profit as % of Assets | 1.5% |
| Profit as % of Stockholder Equity | 2% |
Management Effectiveness
| Return on Equity | 2% |
| Return on Assets | 1% |
| Turnover Ratio | 44% |
| EBITA | $-438,042 |
Balance Sheet and Cash Flow Measures
| Total Assets | $15,108,792 |
| Total Liabilities | $7,834,788 |
| Operating Cash Flow | $716,344 |
| Investing Cash Flow | $-463,862 |
| Financing Cash Flow | $-354,416 |
